Literature DB >> 24733546

Response to letter regarding article, "stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease".

Bobak Heydari1, Raymond Y Kwong.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24733546      PMCID： PMC4382358          DOI： 10.1161/CIRCULATIONAHA.114.008031

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease.

Authors:  Ravi Shah; Bobak Heydari; Otavio Coelho-Filho; Venkatesh L Murthy; Siddique Abbasi; Jiazhuo H Feng; Michael Pencina; Tomas G Neilan; Judith L Meadows; Sanjeev Francis; Ron Blankstein; Michael Steigner; Marcelo di Carli; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circulation       Date:  2013-06-26       Impact factor: 29.690

2.  Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.

Authors:  Leslee J Shaw; William S Weintraub; David J Maron; Pamela M Hartigan; Rory Hachamovitch; James K Min; Marcin Dada; G B John Mancini; Sean W Hayes; Robert A O'Rourke; John A Spertus; William Kostuk; Gilbert Gosselin; Bernard R Chaitman; Merill Knudtson; John Friedman; Piotr Slomka; Guido Germano; Eric R Bates; Koon K Teo; William E Boden; Daniel S Berman
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

3.  Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.

Authors:  Stuart Watkins; Ross McGeoch; Jonathan Lyne; Tracey Steedman; Richard Good; Mairi-Jean McLaughlin; Tony Cunningham; Vladimir Bezlyak; Ian Ford; Henry J Dargie; Keith G Oldroyd
Journal:  Circulation       Date:  2009-11-16       Impact factor: 29.690

4.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.